Zefeng Shen
Papers
1
Total Citations
1
H-Index
1
About
Dr. Zefeng Shen is a pioneering hepatobiliary surgeon whose research focuses on advanced, multimodal treatments for hepatocellular carcinoma (HCC), particularly through the integration of robotic-assisted surgery with locoregional and systemic therapies. His most cited work, a 2025 case report and literature review, demonstrates a groundbreaking approach: successfully performing robotic-assisted liver resection after Yttrium-90 radioembolization combined with targeted therapy and immunotherapy for initially unresectable HCC. This contribution highlights a paradigm shift in converting advanced, inoperable tumors to resectable status, offering new hope for patients with limited options. While early in its citation impact, this work underscores Shen’s role at the forefront of minimally invasive oncologic surgery. His research bridges interventional radiology, immunotherapy, and robotic precision, showcasing a comprehensive strategy that could redefine treatment algorithms for advanced HCC. Dr. Shen’s achievements reflect a commitment to pushing surgical boundaries, with potential to influence future clinical guidelines and inspire further investigation into combined-modality approaches for aggressive liver cancers.
Research Focus
Key Achievements
Top Papers
- 1